Why the study?
Does ondansetron ODT reduce postdischarge vomiting in ASA I and II patients undergoing outpatient gynecological laparoscopy?
Population
60 ASA I and II patients undergoing outpatient gynecological laparoscopy
Comparison
Ondansetron orally disintegrating tablet 8 mg… vs Identical placebo tablet immediately before…
Design
RCT, Randomly allocated, Identical placebo tablet; research personnel unaware…
Follow-up
24 hours
Authors
Loading...
Supports ondansetron ODT for postdischarge PONV prevention in outpatient gynecologic laparoscopy; extends RCT evidence to ambulatory discharge.
Does ondansetron ODT reduce postdischarge vomiting in ASA I and II patients undergoing outpatient gynecological laparoscopy?
Ondansetron ODT significantly reduces the incidence of postdischarge nausea and vomiting and improves patient satisfaction after ambulatory surgery.
Gan et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: